Vimarsana
Biggest News Aggregation in the World

Page 27 - Intern Med News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Intern Med. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Intern Med Today - Breaking & Trending Today

Ultomiris regulatory submission accepted under FDA Priority Review in the US for adults with generalised myasthenia gravis - Vimarsana News

Ultomiris regulatory submission accepted under FDA Priority Review in the US for adults with generalised myasthenia gravis

Submission based on positive Phase III trial in which Ultomiris significantly improved functional activities as measured by Myasthenia Gravis-Activities of Daily Living Profile  

COMMENTARY: What can masks do? Part 2: What makes for a good mask study — and why most fail - Vimarsana News

COMMENTARY: What can masks do? Part 2: What makes for a good mask study — and why most fail

Experts detail the necessary elements of a rigorous mask study and explore some recent studies that, though highly touted by both scientists and the lay press, fell quite a bit short.

Source: umn.edu
Colchicine Promising for Autoimmune Pancreatitis? - Vimarsana News

Colchicine Promising for Autoimmune Pancreatitis?

Case studies of two young men in Italy show benefit, but expert urges caution

Antihypertensive Add-On Has Edge Over Boosting Doses - Vimarsana News

Antihypertensive Add-On Has Edge Over Boosting Doses

Despite adherence issues, blood pressure effect shines in observational data

Perfect FIT for Colorectal Cancer Screening? - Vimarsana News

Perfect FIT for Colorectal Cancer Screening?

email article A novel protein-based multitarget fecal immunochemical test (mFIT) for colorectal cancer (CRC) screening was superior to conventional FIT in detecting advanced neoplasia, particularly advanced adenomas, Dutch researchers found. If performed on patients every 2 years, mFIT would reduce CRC incidence and death by 12% and 8%, respectively, assuming a 73% adherence rate, compared with conventional FIT screening, reported Meike de Wit, PhD, of The Netherlands Cancer Institute in Amsterdam, and colleagues. These rates would increase to 17% and 11%, respectively, with perfect adh...